This famous biannual event will provide state of the art knowledge on endourology, technology, and enable delegates to bestow best and up-to-date practice to their patients.
Experts in endourology will give insightful lectures on the evaluation of technology and best dietary and drug therapy in stone disease, bladder outlet obstruction, and upper tract urological cancer (UTUC). The controversies of biopsy in UTUC is now cleared to again enable best practice in this area.
There will also be a unique technology exhibition from the industry.
Topics to be covered include:
Can’t attend in person on the day? This event is available to watch online via a live stream. Please register to book the live stream here.
CPD learning accredited.
This event is being offered free of charge to all trainees due to funding from the Urology Section.
The Urology Section would like to thank our Annual Sponsor KARL STORZ Endoscopy (UK) Ltd for their valued support of the entire 2021 to 2022 Academic Programme.
We would also like to thank our Platinum Sponsor Cook UK Limited, as well as our sponsors Albyn Medical, Allergan, Boston Scientific, CJ Medical, Coloplast, Macromed, Olympus, Rocamed SAM and STORZ MEDICAL for their support of this meeting.
Please note that the scientific programme and content has not been influenced in any way by the sponsors listed above.
Join in the conversation online using #RSMUrology
Follow us on Twitter: @RoySocMed and @RSMUrology
Consultant Urologist, Academic Medical Centre University Hospital, Amsterdam
Dr Joyce Baard completed her medical degree at the University of Groningen, the Netherlands. Her main fields of interests are the endourologic treatment of stones and urothelial tumours of lower and upper tract. She is especially focused on the endoscopic management of upper urinary tract urothelial cell carcinoma and new imaging and diagnostic techniques.
Professor of Medicine and Physiology, New York University Langone Health
Dr David S. Goldfarb is a Professor of Medicine and Physiology at New York University (NYU) School of Medicine, Clinical Chief of Nephrology at NYU, Chief of Nephrology at the New York Veterans Affairs Medical Centre and Co-Director of the Kidney Stone Prevention Program at NYU Langone Medical Centre.
He graduated from Yale College and Yale School of Medicine and completed his residency training in internal medicine and his nephrology training at NYU/New York Veterans Agency. Dr Goldfarb is the former President of the New York Society of Nephrology and of the Research on Calculus Kinetics Society. He serves as the principal investigator of the cystinuria component of the Rare Kidney Stone Consortium, and as a member of the board of directors of the International Cystinuria Foundation. He is on the editorial boards of Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, Kidney International, Current Opinion in Nephrology and Hypertension and Urolithiasis.
He received the Stone Crusher of the Year award in 2014 from the Oxalosis and Hyperoxaluria Foundation and the Nephrologist of the Year award in 2016 from the American Kidney Fund. He has had three calcium oxalate kidney stones, including one extracorporeal shock wave lithotripsy.
Senior Scientist and Clinical Nutritionist, University of Wisconsin School of Medicine and Public Health, and UW Health University Hospital
Dr Kristina Penniston is a registered dietitian nutritionist at the University Hospital at the University of WisconsinMadison and has been the dietitian in the multidisciplinary UW Health Metabolic Stone Clinic for 22 years.
Since 2005 she has also been a research scientist in the Department of Urology at the University of Wisconsin School of Medicine and Public Health. Dr Penniston’s research has focused broadly on the nutritional management of kidney stone disease, the effectiveness of medical nutrition therapy to reduce stone risk and recurrence, and strategies to improve
clinical management and follow-up of patients with urolithiasis. Her work includes clinical studies and the development of a porcine model of calcium oxalate stone disease, Additionally, she was the primary developer of the Wisconsin Stone Quality of Life questionnaire and the PI of a multi-national consortium of academic urology centres
that study health-related quality of life in patients who form kidney stones. She is a member of the Research on Calculus Kinetics (ROCK) Society and is currently serving a
5-year term as Secretary-Treasurer.
Dr Penniston recently received funding from the National Institute of Diabetes, Digestive, and Kidney Diseases to lead a coordinating
centre for a consortium of research groups in the US studying benign urologic diseases.
Professor Seshadri Sriprasad, President, Urology Section, Royal Society of Medicine
Chairs: Mr Matthew Bultitude, Consultant Urological Surgeon and Clinical Director, Guy's and St Thomas' NHS Foundation Trust and Miss Sian Allen, Consultant Urological Surgeon, University College London Hospitals NHS Foundation Trust
Professor Ben Turney, Associate Professor, Nuffield Department of Surgical Sciences, University of Oxford
Professor Bhaskar Somani, Consultant Urological Surgeon, University Hospital Southampton NHS Foundation Trust
Mr Oliver Wiseman, Consultant Urologist, Cambridge University Hospitals NHS Foundation Trust
Mr Alastair Rodgers, Consultant Urological Surgeon, The Newcastle upon Tyne Hospitals NHS Foundation Trust
Mr Hari Ratan, Consultant Urological Surgeon, Nottingham University Hospitals NHS Trust
Dr Joyce Baard, Consultant Urologist, Academic Medical Centre University Hospital, Amsterdam
Chairs: Ms Kay Thomas, Consultant Urological Surgeon and Deputy Medical Director, Guy's and St Thomas' NHS Foundation Trust and Mr Hari Ratan
Dr Padmini Manghat, Chemical Pathologist, Dartford and Gravesham NHS Trust
Dr David S Goldfarb, Professor of Medicine and Physiology, New York University Langone Health
Dr Kristina Penniston, Senior Scientist, University of Wisconsin School of Medicine and Public Health
Dr Shabbir Moochala, Consultant Nephrologist and Physician, Royal Free London NHS Foundation Trust
Mr Ranan Dasgupta, Consultant Urological Surgeon, The London Clinic
Chairs: Professor Seshadri Sriprasad and Ms Susan Willis, Consultant Urological Surgeon, Guy's and St Thomas' NHS Foundation Trust
Mr Richard Hindley, Consultant Urologist, Hampshire Hospitals NHS Foundation Trust
Mr Wasim Mahmalji, Consultant Urologist, Wye Valley NHS Trust
Mr Marios Hadjipavlou, Consultant Urological Surgeon, Guy's and St Thomas' NHS Foundation Trust
Mr Dominic Hodgson, Consultant Urologist, Portsmouth Hospitals University NHS Trust
Mr Ranan Dasgupta
Dr Clare Bent, Consultant Interventional Radiologist, University Hospitals Dorset NHS Foundation Trust
Mr Gordon Muir, Consultant Urologist, King's College Hospital NHS Foundation Trust
Including vote on scenarios
Chairs: Mr Daron Smith, Consultant Urological Surgeon, University College London Hospitals NHS Foundation Trust and Mr Jonathan Glass, Consultant Urologist, Guy's and St Thomas' NHS Foundation Trust
Panel: Miss Sian Allen, Dr David S Goldfarb, Dr Kristina Penniston, Ms Kay Thomas, Mr Subu Subramonian, Consultant Urologist, University Hospitals Birmingham NHS Foundation Trust, BMI The Priory Hospital and Mr Faqar Anjum, Consultant Urological Surgeon, Dartford and Gravesham NHS Trust
Open to all delegates
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Disclaimer: All views expressed at this event are of the speakers themselves and not of the RSM nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
All delegates will receive the recording of this event 24 hours after the event has finished. The recording will be available to watch for up to 60 days after the live event.
